By Professor Caroline Ford

Journal articles

Ford CE; Henry C; Llamosas E; Djordjevic A; Hacker N, 2016, 'Wnt signalling in gynaecological cancers: A future target for personalised medicine?', Gynecologic Oncology, 140, pp. 345 - 351, http://dx.doi.org/10.1016/j.ygyno.2015.09.085

Henry CE; Knipprath-Meszaros AM; Llamosas E; Schotzau A; Obermann E; Fink D; Hacker N; Ward RL; Heinzelmann-Schwarz V; Ford CE, 2015, 'ROR2 IS A NOVEL TARGET OF THE WNT SIGNALING PATHWAY INVOLVED IN METASTASIS AND CHEMOTHERAPY RESISTANCE', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 25, pp. 476 - 476, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000377145701094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Henry C; Quadir A; Hawkins NJ; Jary E; Llamosas E; Kumar D; Daniels B; Ward RL; Ford CE, 2015, 'Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling', Journal of Cancer Research and Clinical Oncology, 141, pp. 243 - 254, http://dx.doi.org/10.1007/s00432-014-1824-y

Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C, 2015, 'Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion', Oncotarget, 6, pp. 40310 - 40326, http://dx.doi.org/10.18632/oncotarget.5643

Ford CE; Punnia-Moorthy G; Henry CE; Llamosas E; Nixdorf S; Olivier J; Caduff R; Ward RL; Heinzelmann-Schwarz V, 2014, 'The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer', Gynecologic Oncology, 134, pp. 338 - 345, http://dx.doi.org/10.1016/j.ygyno.2014.06.004

Ford CE; Ma SSQ; Quadir A; Ward RL, 2013, 'The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis', International Journal of Cancer, 133, pp. 779 - 787, http://dx.doi.org/10.1002/ijc.27984

Ford CE; Jary E; Ma SSQ; Nixdorf S; Heinzelmann-Schwarz VA; Ward RL, 2013, 'The WNT gatekeeper SFRP4 modulates EMT, cell migration and downstream WNT signalling in serous ovarian cancer cells', PLoS ONE, 8, pp. e54362, http://dx.doi.org/10.1371/journal.pone.0054362

Loh YN; Hedditch E; Baker L; Jary E; Ward RL; Ford CE, 2013, 'The Wnt signalling pathway is upregulated in acquired Tamoxifen resistant breast cancer.', BMC Cancer, 13, pp. 174, http://dx.doi.org/10.1186/1471-2407-13-174

Ford CE; Jary E; Ma S; Nixdorf S; Heinzelmann-Schwarz V; Ward RL, 2012, 'SFRP4 modulates EMT, cell migration and downstream Wnt signalling in epithelial ovarian cancer.', CANCER RESEARCH, 72, http://dx.doi.org/10.1158/1538-7445.AM2012-333

Jacob F; Ukegjini K; Nixdorf S; Ford CE; Olivier J; Caduff R; Scurry J; Guertler R; Hornung D; Mueller R; Fink D; Hacker NF; Heinzelmann-Schwarz VA, 2012, 'Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients', PLoS One, 7, pp. Art no. e31885, http://dx.doi.org/10.1371/journal.pone.0031885

Ford CE; Ekström EJ; Howlin J; Andersson T, 2011, 'The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer (Cell Cycle (2009), 8, (1838-1842))', Cell Cycle, 10, pp. 1167, http://dx.doi.org/10.4161/cc.10.7.15488

Johal H; Ford CE; Glenn W; Heads J; Lawson JS; Rawlinson WD, 2011, 'Mouse mammary tumor like virus sequences in breast milk from healthy lactating women', Breast Cancer Research and Treatment, 129, pp. 149 - 155, http://dx.doi.org/10.1007/s10549-011-1421-6

Ford CE; Ekström EJ; Andersson T, 2010, 'Erratum: Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells (Proceedings of the National Academy of Sciences of the United Stated of America (2010) 106 (3919-3924) DOI: 10.1073/pnas.0809516106))', Proceedings of the National Academy of Sciences of the United States of America, 107, pp. 22360, http://dx.doi.org/10.1073/pnas.1017549108

Ford CE; Ekström EJ; Howlin J; Andersson T, 2009, 'The WNT-5a derived peptide, Foxy-5, possesses dual properties that impair progression of ERα negative breast cancer', Cell Cycle, 8, pp. 1838 - 1842, http://dx.doi.org/10.4161/cc.8.12.8863

Ford CE; Ekström EJ; Andersson T, 2009, 'Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells', Proceedings of the National Academy of Sciences of the United States of America, 106, pp. 3919 - 3924, http://dx.doi.org/10.1073/pnas.0809516106

Ford CE; Lau S; Zhu CQ; Andersson T; Tsao M; Vogel W, 2007, 'Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma.', British Journal of Cancer, 96, pp. 808 - 814, http://dx.doi.org/10.1038/sj.bjc.6603614

Lawson JS; Tran D; Carpenter E; Ford C; Rawlinson WD; Whitaker NJ; Delprado W, 2006, 'Presence of mouse mammary tumour-like virus gene sequences may be associated with morphology of specific human breast cancer', Journal of Clinical Pathology, 59, pp. 1287 - 1292

Vogel W; Abdulhussein R; Ford CE, 2006, 'Sensing extracellular matrix: An update on discoidin domain receptor function.', Cellular Signalling, 18, pp. 1108 - 1116

Pogo B; Menard S; Holland JF; Faedo M; Ford CE; Rawlinson WD, 2005, 'Contribution by Faedo et al. (Clin Cancer Res 2004;10:4417-4419) [1]', Clinical Cancer Research, 11, pp. 406

Faedo M; Ford CE; Rawlinson WD, 2005, 'Contribution by Faedo et al. Response', CLINICAL CANCER RESEARCH, 11, pp. 406 - 406, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000226110300054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ford CE; Faedo M; Delprado W; Rawlinson WD, 2004, 'Correspondence re: C. Ford, et al. Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women.', Clinical Cancer Research, 10, pp. 802 - 802

Lawson JS; Tran D; Ford CE; Rawlinson WD, 2004, 'Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer', Breast Cancer Research and Treatment, 87, pp. 13 - 17

Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD, 2004, 'Mouse mammary tumor like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer', Clinical Cancer Research, 10, pp. 4417 - 4419

Ford CE; Faedo M; Rawlinson WD, 2004, 'Mouse mammary tumor virus-like RNA transcripts and DNA are found inaffected cells of human breast cancer', Clinical Cancer Research, 10, pp. 7284 - 7289

Ford CE; Faedo M; Lawson JS; Rawlinson WD; Crouch R, 2004, 'Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in men and women.', Cancer research, 64, pp. 4755 - 4759

Ford CE; Tran D; Deng Y; Ta VT; Rawlinson WD; Lawson JS, 2003, 'Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women', Clinical Cancer Research, 9, pp. 1118 - 1120

Conference Papers

Werner B; Powell E; Duggan J; Lee YC; Athavale R; Dean M; Warton K; Ford C, 2023, 'PR004/#458  Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in a cohort of patients with advanced ovarian cancer', in Featured Posters: Poster Rounds with the Professors, BMJ Publishing Group Ltd, presented at IGCS 2023 Annual Meeting Abstracts, http://dx.doi.org/10.1136/ijgc-2023-igcs.47

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Köbel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Abstract 1045: Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy', in Cancer Research, American Association for Cancer Research (AACR), pp. 1045 - 1045, http://dx.doi.org/10.1158/1538-7445.am2021-1045

Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Abstract 1062: Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody', in Cancer Research, American Association for Cancer Research (AACR), pp. 1062 - 1062, http://dx.doi.org/10.1158/1538-7445.am2021-1062

Xu X; Wang Y; Bryce N; Tang K; Meagher NS; Kang EY; Kelemen LE; Kobel M; Ramus SJ; Friedlander M; Ford CE; Hardeman EC; Gunning PW, 2021, 'Combined targeting of actin/tropomyosin and microtubules underlies a potential treatment strategy of epithelial ovarian cancer with cell-cycle dependent synergy.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000680263503257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu D; Kaufmann GF; Breitmeyer JB; Dickson K-A; Marsh DJ; Ford CE, 2021, 'Inhibition of ovarian and endometrial cancer cell proliferation by an anti-ROR1 monoclonal antibody.', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000680263503274&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2021, 'Abstract PO042: ROR2 is epigenetically regulated in endometrial cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. PO042 - PO042, http://dx.doi.org/10.1158/1557-3265.endomet20-po042

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2020, 'Abstract A41: ROR1 is associated with ovarian cancer progression and chemoresistance', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. A41 - A41, http://dx.doi.org/10.1158/1557-3265.ovca19-a41

Warton K; Yuwono N; Henry C; Hacker N; Ford C, 2020, 'Abstract B28: Optimizing DNA processing and ovarian cancer methylation-specific PCR assays for the detection of early-stage ovarian cancer', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. B28 - B28, http://dx.doi.org/10.1158/1557-3265.ovca19-b28

Warton K; Yuwono N; Henry C; Hacker N; Ford C, 2019, 'Optimizing DNA processing and ovarian cancer methylation-specific PCR assays for the detection of early-stage ovarian cancer.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, pp. 93 - 93, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300143&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Henry CE; Hacker NF; Ford CE, 2018, 'Shock and ROR! Targeting ROR1 and ROR2 in a preclinical patient-derived model of ovarian cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, IL, Chicago, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), IL, Chicago, 14 April 2018 - 18 April 2018, http://dx.doi.org/10.1158/1538-7445.AM2018-106

Henry CE; Llamosas E; Hacker NF; Heinzelmann-Schwarz V; Ford CE, 2016, 'The role of the ROR receptors in ovarian cancer progression and chemoresistance', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, LA, New Orleans, presented at 107th Annual Meeting of the American-Association-of-Cancer-Research (AACR), LA, New Orleans, 16 April 2016 - 20 April 2016, http://dx.doi.org/10.1158/1538-7445.AM2016-1636

Ford CE; Tuomela J; Hedditch EL; Axelsson L; Liu Q; Ward RL; Harkonen P; Andersson T, 2010, 'Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5', in EJC SUPPLEMENTS, PERGAMON-ELSEVIER SCIENCE LTD, NORWAY, Oslo, pp. 11 - 11, presented at 21st Meeting of the European-Association-for-Cancer-Research, NORWAY, Oslo, 26 June 2010 - 29 June 2010, http://dx.doi.org/10.1016/S1359-6349(10)70852-1

Kennedy S; Waliuzzaman Z; Ford C; Rawlinson W; Pussell B, 2005, 'Recurrent HUS following kidney transplant possibly precipitated by CMV', in IMMUNOLOGY AND CELL BIOLOGY, BLACKWELL PUBLISHING, AUSTRALIA, Canberra, pp. A16 - A17, presented at 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, AUSTRALIA, Canberra, 11 May 2005 - 13 May 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230636500066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Posters

Chisholm OT; Gomes L; Thai T; Nixdorf S; Williams R; Clayphan A; Vigentini L; Zhang C; Zhao L; King M; Ford C, (ed.), 2016, 'Empowering Online Learners Using Assessment and Feedback', UNSW, presented at Towards 2025: Inspiring Learning, UNSW, 31 October 2016 - 31 October 2016

Conference Presentations

Nixdorf S; Chisholm OT; Gomes L; Ford C, 2016, 'Student Engagement in the Personalised Medicine MOOC: Does the Learning Platform Matter?', presented at UNSW Medicine Learning and Teaching Forum, UNSW, Sydney, 07 December 2016 - 07 December 2016

Ford C; Chisholm O; Gomes L, 2016, 'The Hope and Hype of the Genetic Revolution: Reflections on UNSW Medicine's First MOOC', presented at Connections Seminar Series, UNSW Australia, UNSW Australia, 19 May 2016 - 19 May 2016

Ford C; Chisholm OT; Gomes L, 2015, 'Hope and Hype: Reflections on UNSW Medicine's First MOOC', presented at 2015 UNSW Medicine Learning and Teaching Forum, UNSW, Sydney, NSW, Australia, 02 December 2015 - 02 December 2015, https://med.unsw.edu.au/annual-learning-and-teaching-forum

Chisholm O; Nixdorf S; Williams R; Ford C, 2014, 'Reflections on the development of an open online course', presented at UNSW Medicine Learning and Teaching Forum 2014, UNSW Australia, 10 December 2014 - 10 December 2014, http://med.unsw.edu.au/annual-learning-and-teaching-forum

Ford C, 2014, 'Hear the Ror! The role of Wnt signalling in ovarian cancer.', presented at International Society for Gynecologic Cancers, Melbourne, 08 November 2014 - 11 April 2015

Ford CE; Henry CE; Llamosas E; Djordjevic A; Hacker NF; Heinzelmann-Schwarz VA; Ward RL, 2014, 'HEAR THE ROR! THE ROLE OF WNT SIGNALLING IN OVARIAN CANCER'

Conference Abstracts

Liu D; Enriquez L; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR2 is epigenetically regulated in endometrial cancer', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 27, presented at AACR Special Conference on Endometrial Cancer - New Biology Driving Research and Treatment, ELECTR NETWORK, 09 November 2020 - 10 November 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000617951200068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Yuwono NL; Warton K; Henry C; Ford C, 2020, 'Deciphering the origin of circulating cell-free DNA and its alterations during menstruation', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-731

Liu D; Gunther K; Daniels B; O'Mara T; Tang K; Ford C, 2020, 'ROR1: A novel target in endometrial cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, ELECTR NETWORK, Vol. 80, presented at AACR Annual Meeting, ELECTR NETWORK, 22 June 2020 - 24 June 2020, http://dx.doi.org/10.1158/1538-7445.AM2020-2942

Liu D; John M; Henry CE; Christie EL; Bowtell DDL; Tang K; Heinzelmann-Schwarz V; Kennedy C; Boros J; DeFazio A; Ford CE, 2019, 'ROR1 is associated with ovarian cancer progression and chemoresistance.', in CLINICAL CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 26, pp. 59 - 60, presented at AACR Special Conference on Advances in Ovarian Cancer Research, GA, Atlanta, 13 September 2019 - 16 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000546013300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page